![Avencia Sánchez-Mejías](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Avencia Sánchez-Mejías
Algemeen Directeur bij Integra Therapeutics SL
Actieve functies van Avencia Sánchez-Mejías
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Integra Therapeutics SL
![]() Integra Therapeutics SL Miscellaneous Commercial ServicesCommercial Services Integra Therapeutics SL is a Spanish Barcelona-based company founded in 2020 by Marc Güell and Avencia Sánchez-Mejías, with Avencia Sánchez-Mejías serving as the CEO since then. The company is focused on engineering the next-generation of gene writing tools to cure genetic and oncological diseases with high unmet medical need. Integra Therapeutics is committed to creating new gene writing tools that improve the scope, efficiency, and safety of advanced therapies. | Algemeen Directeur | - | - |
Oprichter | - | - |
Loopbaan van Avencia Sánchez-Mejías
Statistieken
Internationaal
Spanje | 2 |
Operationeel
Chief Executive Officer | 1 |
Founder | 1 |
Sectoraal
Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Integra Therapeutics SL
![]() Integra Therapeutics SL Miscellaneous Commercial ServicesCommercial Services Integra Therapeutics SL is a Spanish Barcelona-based company founded in 2020 by Marc Güell and Avencia Sánchez-Mejías, with Avencia Sánchez-Mejías serving as the CEO since then. The company is focused on engineering the next-generation of gene writing tools to cure genetic and oncological diseases with high unmet medical need. Integra Therapeutics is committed to creating new gene writing tools that improve the scope, efficiency, and safety of advanced therapies. | Commercial Services |